Health Care & Life Sciences » Biotechnology | Anhui Anke Biotechnology

Anhui Anke Biotechnology | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
318
189
184
214
183
146
Total Accounts Receivable
87
189
214
278
381
499
Inventories
29
32
53
61
76
96
Other Current Assets
6
8
9
11
72
15
Total Current Assets
440
418
460
564
712
756
Net Property, Plant & Equipment
283
358
445
505
541
633
Total Investments and Advances
8
10
26
61
169
221
Intangible Assets
16
116
435
797
788
867
Other Assets
-
2
2
26
12
26
Total Assets
750
916
1,401
1,965
2,254
2,527
ST Debt & Current Portion LT Debt
-
-
-
238
177
Accounts Payable
38
35
39
56
65
Income Tax Payable
12
16
17
55
40
Other Current Liabilities
38
88
47
105
118
Total Current Liabilities
88
140
102
454
401
Long-Term Debt
-
-
-
50
50
Provision for Risks & Charges
-
1
-
-
-
Deferred Taxes
3
11
7
5
17
Other Liabilities
-
-
-
-
28
Total Liabilities
88
140
128
521
494
Common Equity (Total)
661
739
1,217
1,359
1,678
Total Shareholders' Equity
661
739
1,217
1,359
1,678
Total Equity
661
773
1,264
1,426
1,760
Liabilities & Shareholders' Equity
750
916
1,401
1,965
2,254
Accumulated Minority Interest
-
35
48
67
83
Non-Equity Reserves
1
2
8
18
-

About Anhui Anke Biotechnology

View Profile
Address
K-1, Haiguan Road
Hefei Anhui 230088
China
Employees -
Website http://www.ankebio.com
Updated 07/08/2019
Anhui Anke Biotechnology (Group) Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. Its business activities include implementation of precision medical development strategy, formation of genetic testing, and development of anti-tumor drugs and cell immunotherapy technology. Its products consist of biological products, modern Chinese medicine, chemical synthetic drugs, peptide active pharmaceutical ingredients, nucleic acid detection, and cosmetic products.